Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?

Cho, Sun Young; Kang, Cheol-In; Kim, Jungok; Ha, Young Eun; Chung, Doo Ryeon; Lee, Nam Yong; Peck, Kyong Ran; Song, Jae-Hoon

Cho, Sun Young; Kang, Cheol-In; Kim, Jungok; Ha, Young Eun; Chung, Doo Ryeon; Lee, Nam Yong; Peck, Kyong Ran; Song, Jae-Hoon.

Affiliation

Cho SY; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Antimicrob Agents Chemother ; 58(1): 581-3, 2014.

Article in En | MEDLINE | ID: mdl-24126583

Subject(s)

Anti-Bacterial Agents/therapeutic use; Gram-Negative Bacterial Infections/drug therapy; Levofloxacin/therapeutic use; Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use; Aged; Anti-Bacterial Agents/adverse effects; Bacteremia/drug therapy; Female; Humans; Levofloxacin/adverse effects; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Trimethoprim, Sulfamethoxazole Drug Combination / Gram-Negative Bacterial Infections / Levofloxacin / Anti-Bacterial Agents Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Antimicrob Agents Chemother Year: 2014 Type: Article Affiliation country: South Korea

Fulltext

XML

PubMed Links

Search on Google